These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 668724)

  • 21. Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions.
    Rao GH; Escolar G; White JG
    Thromb Res; 1986 Oct; 44(1):65-74. PubMed ID: 3787562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet serotonin in newborns and infants: ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors.
    Anderson GM; Czarkowski K; Ravski N; Epperson CN
    Pediatr Res; 2004 Sep; 56(3):418-22. PubMed ID: 15240861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human platelets.
    Barradas MA; Jagroop IA; Mikhailidis DP
    Clin Chim Acta; 1994 Oct; 230(2):157-67. PubMed ID: 7834867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
    Tandon NN; Ordinas A; Jamieson GA
    Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The synergistic effect of 5-hydroxytryptamine and epinephrine on the human platelet is related to the activation of phospholipase C.
    Roevens P; De Clerck F; de Chaffoy de Courcelles D
    Eur J Pharmacol; 1993 May; 245(3):273-80. PubMed ID: 8335063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine treated patients due to changes in platelet properties.
    Boullin DJ; Grahame-Smith DG; Grimes RP; Woods HF
    Br J Clin Pharmacol; 1975 Feb; 2(1):37-9. PubMed ID: 791317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein phosphorylation and diglyceride production during serotonin release induced by epinephrine plus ADP in human platelets.
    Kawahara Y; Yamanishi J; Tsunemitsu M; Fukuzaki H
    Thromb Res; 1983 Jun; 30(5):477-85. PubMed ID: 6612681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epinephrine-induced reversal of aspirin effects on platelet deformability.
    Smith CM; Burris SM; Rao GH; White JG
    Thromb Res; 1988 Jul; 51(1):35-44. PubMed ID: 3413735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.
    Boullin DJ; Grimes RP; Orr MW
    Br J Pharmacol; 1975 Dec; 55(4):555-7. PubMed ID: 2360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes.
    Malyszko J; Urano T; Knofler R; Taminato A; Yoshimi T; Takada Y; Takada A
    Thromb Res; 1994 Sep; 75(5):569-76. PubMed ID: 7992257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synergistic effect of serotonin and epinephrine on the human platelet at the level of signal transduction.
    de Chaffoy de Courcelles D; Roevens P; Van Belle H; De Clerck F
    FEBS Lett; 1987 Jul; 219(2):283-8. PubMed ID: 3609294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
    Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ
    J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of the cyclic GMP concentration in human platelets by sodium ascorbate and 5-hydroxytryptamine.
    Schoepflin GS; Pickett W; Austen KF; Goetzl EJ
    J Cyclic Nucleotide Res; 1977 Oct; 3(5):355-65. PubMed ID: 201683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of platelet aggregation in vitro by microbubbles of nitrogen.
    Thorsen T; Lie RT; Holmsen H
    Undersea Biomed Res; 1989 Nov; 16(6):453-64. PubMed ID: 2603242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
    Bailey SR; Andrews MJ; Elliott J; Cunningham F
    Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human platelet function by verapamil.
    Addonizio VP; Fisher CA; Strauss JF; Edmunds LH
    Thromb Res; 1982 Nov; 28(4):545-56. PubMed ID: 7164035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet aggregability, disaggregability and serotonin uptake in migraine.
    Kruglak L; Nathan I; Korczyn AD; Zolotov Z; Berginer V; Dvilansky A
    Cephalalgia; 1984 Dec; 4(4):221-5. PubMed ID: 6518502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.